Teva Announces Presence at Major Healthcare Conferences
Israeli-based Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is set to feature prominently in two upcoming major investor conferences. Members from the executive management team will share valuable insights into the company's advancements and strategies, demonstrating their ongoing commitment to innovation in healthcare.
Upcoming Events
Jefferies Global Healthcare Conference
Teva’s first appearance will be at the Jefferies Global Healthcare Conference. Scheduled for June 4, this event will highlight the roles of Chris Fox, EVP U.S. Commercial, and Dr. Eric Hughes, EVP Global R&D and Chief Medical Officer. This presentation will begin at 9:20 am ET, offering investors an overview of Teva’s strategic direction and market initiatives.
Goldman Sachs Global Healthcare Conference
The second event will take place at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10. Richard Francis, President & CEO, will represent Teva at this significant conference, where his insights, scheduled at 8:00 am ET, will further illustrate the company’s innovative approach in a competitive field.
Accessing the Webcast
To stay informed on these presentations, you can access a live webcast via Teva’s Investor Relations website. Following the presentations, an archived version will be available within 24 hours, allowing stakeholders to catch up on highlights and details shared during both events.
About Teva
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical leader that has been committed to bettering health for over 120 years. The company employs around 37,000 individuals across 57 markets, dedicated to delivering innovative treatments, alongside a robust portfolio of generics and biologics. Teva’s mission is clear: addressing patient needs worldwide through extensive research and development, paving the way for the future of medicine.
Frequently Asked Questions
What is the main focus of Teva's presentation at the conferences?
Teva will focus on their strategic initiatives, innovations in pharmaceutical development, and the company’s direction in the healthcare market.
Who are the key speakers representing Teva?
Chris Fox and Dr. Eric Hughes will present at the Jefferies Global Healthcare Conference, while Richard Francis will speak at the Goldman Sachs conference.
When are the conferences taking place?
The Jefferies Global Healthcare Conference is on June 4, and the Goldman Sachs conference is scheduled for June 10.
How can the public access the webcasts of these presentations?
Webcasts can be accessed live on Teva’s Investor Relations website, with archived versions available shortly after each event concludes.
What distinguishes Teva from other pharmaceutical companies?
Teva is known for its comprehensive focus on both innovative and generic medications, stating a strong commitment to addressing global healthcare challenges effectively.
